MedTrace Logo

Continuation of Patient Follow-up to 2 Years for the Pinnacle RSA and Pinnacle DM RSA Clinical Trials

NCT05930067 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2025-12-10

No results posted yet for this study

Summary

The proposed study is a continuation of two prospective, multi-centre, non-controlled studies of the Pinnacle and Pinnacle Dual Mobility total hip arthroplasty systems, originally initiated by DePuy Synthes (DSJ\_2018\_02 and DJS\_2019\_02, respectively).

Conditions

  • Hip Osteoarthritis

Interventions

DEVICE

Pinnacle Gription Acetabular Cup

Pinnacle Gription cup with Corail/ACTIS stem

DEVICE

Pinnacle Dual Mobility

Bi-Mentum AltrX liner

Sponsors & Collaborators

  • DePuy Synthes

    collaborator INDUSTRY

  • Canadian Radiostereometric Analysis Network

    lead OTHER

Principal Investigators

  • Thomas Turgeon, MD · Concordia Joint Replacement Group

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-02
Primary Completion
2025-03-12
Completion
2025-05-30
FDA Device
Yes

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05930067 on ClinicalTrials.gov